Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Horineves

2 clinical trials in Horineves, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Horineves at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

2 trials in Horineves

Open in trial search

COVID-19

Recruiting

Study of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness

Investigational
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ibuzatrelvir
  • Sponsor:Pfizer Inc.

Erythema migrans+1

Not recruiting

Study on the Effects of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Health in Patients with Early Lyme Disease Undergoing Antibiotic Treatment

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Biocodex

Other cities in Czechia

The busiest research cities in the country

All 159 cities in Czechia

Clinical research in Horineves

What the registry says about research in the country

01 Digestive System Diseases

Clinical research in Horineves is examining how treatments affect the gut microbiota in people receiving antibiotic therapy, with a focus on digestive health during care for erythema migrans linked to early Lyme borreliosis.

  • Impact of Saccharomyces boulardii CNCM I-745 on intestinal balance
  • Supportive care during antibiotic use
  • Microbiome changes in early Lyme-related skin infection

The trial aims to better understand whether a probiotic can help maintain digestive stability alongside treatment.

02 Virus Diseases

Another study in Czechia is focused on COVID-19 in adults and adolescents who are not hospitalized but remain at higher risk of developing severe illness.

  • Evaluation of a new antiviral therapy
  • Nonhospitalized patients with COVID-19
  • Reducing the chance of severe disease progression

This research is designed to assess whether the study medicine can improve outcomes for people early in the course of infection.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.